SEC Form 4 · accession 0001209191-15-052366
OCULAR THERAPEUTIX, INC · OCUL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles M Warden
Director · 10% Owner
Period of report
Jun 10, 2015
Accepted (ET)
Jun 11, 2015 · 5:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001393434
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 10, 2015 | S | 424,494 | $22.00 | D | 2,520,499 | I | See Footnote |
| Common StockF2 | Jun 10, 2015 | S | 2,506 | $22.00 | D | 14,885 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These securities are directly held by Versant Venture Capital III, L.P. Versant Ventures III, LLC is the general partner of Versant Venture Capital III, L.P. The Reporting Person is a mananging member of Versant Ventures III, LLC and disclaims beneficial ownership of the securities listed above except to the extent of his pecuniary interest, if any, therein.
- F2These securities are directly held by Versant Side Fund III, L.P. Versant Ventures III, LLC is the general partner of Versant Side Fund III, L.P. The Reporting Person is a mananging member of Versant Ventures III, LLC and disclaims beneficial ownership of the securities listed above except to the extent of his pecuniary interest, if any, therein.